Brightspring Health Services Inc (BTSG) valuation
Brightspring Health Services P/E ratio history
Brightspring Health Services trades at 40.5 times its earnings over the last twelve months and 32.7 times the earnings analysts expect over the next twelve.
| Fiscal year ended | Price | EPS | P/E | Forward P/E |
|---|---|---|---|---|
| Dec 31, 2025 | $37.45 | $0.87 | 43.1 | 31.7 |
| Dec 31, 2024 | $17.03 | -$0.09 | n/m | 24.8 |
n/m: not meaningful (a loss, or earnings close to zero). The daily P/E line is a chart indicator in the app.
Brightspring Health Services valuation against its peers
| Company | Market value | P/E | Forward P/E | Price / sales |
|---|---|---|---|---|
| Brightspring Health ServicesBTSG | $13.0B | 40.5 | 32.7 | 0.9 |
| GlaukosGKOS | $14.0B | — | 223.7 | 20.3 |
| DaVitaDVA | $12.0B | 13.9 | 11.4 | 0.8 |
| SolventumSOLV | $14.1B | 9.9 | 11.3 | 1.7 |
| Baxter InternationalBAX | $11.9B | — | 11.2 | 1.0 |
| Cooper Companies (The)COO | $11.6B | 20.4 | 12.8 | 2.7 |
| Bridgebio PharmaBBIO | $14.7B | — | — | 15.5 |
| Bio-TechneTECH | $11.4B | 62.6 | 35.7 | 9.4 |
| Align TechnologyALGN | $10.7B | 26.1 | 12.5 | 2.6 |
| Peer median | 20.4 | 12.5 | 2.7 |
Reading these multiples
The P/E divides the share price by earnings per share over the last twelve months; the forward P/E divides it by the earnings analysts expect over the next twelve. Price to sales compares the company's market value with its revenue over the last twelve months. A multiple reads differently from one industry to the next, so the peer group above is the fairer comparison.
See also: BTSG financials · BTSG returns
No forecast, no recommendation. This page describes Brightspring Health Services Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.